News | Cardiovascular Ultrasound | March 31, 2022

DiA Imaging Analysis Teams up with Healthcare Technology Company to Expand its AI Offering for Echo-lab Cardiac Exams

DiA’s cardiac ultrasound AI will be implemented into Healthcare Technology Company’s CPACS workflow automating echo labs readflow and improving insights for imaging specialists

DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global industry-leading provider of enterprise imaging solutions.

March 31, 2022 – DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global industry-leading provider of enterprise imaging solutions. Change Healthcare's proven cardiology solutions, along with DiA's AI-based algorithms, will benefit echocardiologists and other imaging specialists by improving the efficiency of routine tasks and the effectiveness of workflow in the Echo Lab reading environment.

Under the agreement, DiA’s FDA-cleared and CE-marked LVivo Seamless solution, an AI-based software for cardiac ultrasound, will be available on Change Healthcare’s imaging solutions in Echo Labs. 

“The use of AI to help improve quality of care is accelerating. We at Change Healthcare pride ourselves on incorporating the most innovative, cutting edge technologies to help our customers provide better quality of care for their patients and increase their operational efficiency,” said Tracy Byers, Senior Vice President and General Manager Enterprise Imaging for Change Healthcare. “We are confident that working with DiA will augment our clinician’s workload, providing a faster and more objective analysis of scans and positively impacting patient outcomes and care.” 

The evaluation of cardiac ultrasound images typically involves eyeballing and manual steps. Variability across readers’ interpretation may be influenced by external factors, such as experience and training background. DiA’s AI-based LVivo Seamless solution automates the workflow and automatically selects and analyzes the optimal cardiac images, generating key clinical indications of both left and right ventricle function that are immediately presented on the CPACS viewer for review.

“For artificial intelligence to be truly valuable, it must be integrated into the clinician’s daily routine and readflow,” said Hila Goldman Aslan, CEO and co-founder of DiA. “Our team at DiA Imaging Analysis is excited to be working with Change Healthcare, making our AI-based software accessible to echocardiologists and sonographers around the world.”

For more information: https://www.dia-analysis.com/

Related Content

News | Cardiovascular Ultrasound

May 10, 2022 — MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies ...

Home May 10, 2022
Home
Feature | Cardiovascular Ultrasound

The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period ...

Home May 05, 2022
Home
News | Cardiovascular Ultrasound

April 29, 2022 – Aurora St. Luke’s Medical Center in Milwaukee is the first site in the country to join a clinical trial ...

Home April 29, 2022
Home
News | Cardiovascular Ultrasound
April 21, 2022 – Coronary artery disease (CAD) is one of the major causes of mortality and morbidity worldwide ...
Home April 21, 2022
Home
News | Cardiovascular Ultrasound

April 20, 2022 – Researchers from the RIKEN Center for Advanced Intelligence Project (AIP) and colleagues have tested AI ...

Home April 20, 2022
Home
News | Cardiovascular Ultrasound

April 2, 2022 — Royal Philips, a global leader in health technology, today announced the launch of Ultrasound Workspace ...

Home April 02, 2022
Home
News | Cardiovascular Ultrasound

December 9, 2021 – Philips Healthcare expanded its cardiac ultrasound portfolio with new imaging tools and features to ...

Home December 09, 2021
Home
Videos | Cardiovascular Ultrasound

Examples of TrueView and GlassView 3D cardiac ultrasound visualization and artificial intelligence (AI) assisted ...

Home November 24, 2021
Home
News | Cardiovascular Ultrasound

October 4, 2021 – UltraSight, a digital health company developing artificial intelligence (AI) enabled cardiac imaging ...

Home October 04, 2021
Home
News | Cardiovascular Ultrasound

September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and ...

Home September 14, 2021
Home
Subscribe Now